Literature DB >> 27105079

Immunophenotypic and diagnostic characterization of angioimmunoblastic T-cell lymphoma by advanced flow cytometric technology.

Sanam Loghavi1, Sa A Wang1, L Jeffrey Medeiros1, Jeffrey L Jorgensen1, Xin Li1, Zijun Y Xu-Monette1, Roberto N Miranda1, Ken H Young1.   

Abstract

Angioimmunoblastic T-cell lymphoma (AITL) often shows systemic symptoms related to immune dysregulation and cytokine production. Biopsy usually harbors few malignant cells in an abundant reactive background, which can be diagnostically challenging in cases with small biopsies. This study was performed to assess the value of flow cytometry (FC) and to determine the immunophenotypic alterations in 155 samples from 38 patients with AITL. FC detected an aberrant T-cell population in 97 of 155 samples that represented 0.5-90% of lymphocytes. Blood was involved in 11 of 16 patients. The most frequent immunophenotypic aberrancies included loss of CD3; altered T-cell receptor expression and aberrant CD10 expression. Altered CD3 expression was more frequently seen in peripheral blood (PB) and bone marrow (BM), whereas aberrant CD10 expression was more common in lymph node (LN). AITL cells often exhibit abnormal CD4+ immunophenotype with diminished or absent CD3 and variable CD10 expression. Multiparameter FC is an effective tool for supporting the diagnosis of AITL in any fluid and various tissue specimens types.

Entities:  

Keywords:  AITL; CD10; CD3; CHOP; T-cell lymphoma; TCR; angioimmunoblastic; flow cytometry

Mesh:

Substances:

Year:  2016        PMID: 27105079      PMCID: PMC5142610          DOI: 10.3109/10428194.2016.1170827

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  27 in total

1.  Identification of circulating CD10 positive T cells in angioimmunoblastic T-cell lymphoma.

Authors:  L Baseggio; F Berger; D Morel; M-H Delfau-Larue; G Goedert; G Salles; J-P Magaud; P Felman
Journal:  Leukemia       Date:  2006-02       Impact factor: 11.528

2.  Hepatosplenic gamma/delta T-cell lymphoma in bone marrow. A sinusoidal neoplasm with blastic cytologic features.

Authors:  F Vega; L J Medeiros; C Bueso-Ramos; D Jones; R Lai; R Luthra; L V Abruzzo
Journal:  Am J Clin Pathol       Date:  2001-09       Impact factor: 2.493

3.  Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study.

Authors:  Pier Paolo Piccaluga; Fabio Fuligni; Antonio De Leo; Clara Bertuzzi; Maura Rossi; Francesco Bacci; Elena Sabattini; Claudio Agostinelli; Anna Gazzola; Maria Antonella Laginestra; Claudia Mannu; Maria Rosaria Sapienza; Sylvia Hartmann; Martin L Hansmann; Roberto Piva; Javeed Iqbal; John C Chan; Denis Weisenburger; Julie M Vose; Monica Bellei; Massimo Federico; Giorgio Inghirami; Pier Luigi Zinzani; Stefano A Pileri
Journal:  J Clin Oncol       Date:  2013-07-15       Impact factor: 44.544

4.  Circulating CD4+ T lymphocytes with intracellular but no surface CD3 antigen in five of seven patients consecutively diagnosed with angioimmunoblastic T-cell lymphoma.

Authors:  S Serke; A van Lessen; M Hummel; A Szczepek; D Huhn; H Stein
Journal:  Cytometry       Date:  2000-06-15

Review 5.  Paraneoplastic phenomena and diagnostic challenges in angioimmunoblastic T-cell lymphoma (AITL): report of two cases and review of the literature.

Authors:  Andreas Pircher; Irmgard Verdorfer; Andrea Brunner; Georg Hopfinger; Michael Steurer
Journal:  In Vivo       Date:  2014 May-Jun       Impact factor: 2.155

6.  The usefulness of flow cytometric CD10 detection in the differential diagnosis of peripheral T-cell lymphomas.

Authors:  Alessandra Stacchini; Anna Demurtas; Sabrina Aliberti; Paola Francia di Celle; Laura Godio; Giorgio Palestro; Domenico Novero
Journal:  Am J Clin Pathol       Date:  2007-11       Impact factor: 2.493

7.  The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells.

Authors:  Laurence de Leval; David S Rickman; Caroline Thielen; Aurélien de Reynies; Yen-Lin Huang; Georges Delsol; Laurence Lamant; Karen Leroy; Josette Brière; Thierry Molina; Françoise Berger; Christian Gisselbrecht; Luc Xerri; Philippe Gaulard
Journal:  Blood       Date:  2007-02-06       Impact factor: 22.113

8.  CD10 expression in extranodal dissemination of angioimmunoblastic T-cell lymphoma.

Authors:  Ayoma D Attygalle; Timothy C Diss; Philippa Munson; Peter G Isaacson; Ming Q Du; Ahmet Dogan
Journal:  Am J Surg Pathol       Date:  2004-01       Impact factor: 6.394

9.  Hypereosinophilic syndrome - lymphocytic variant transforming into peripheral T-cell lymphoma with severe oral manifestations.

Authors:  J M d'Elbée; M Parrens; P Mercié; M Longy Boursier; C Dieval; A de Mascarel; P Duffau; P Dubus; J C Fricain
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2013-05-10

10.  Angioimmunoblastic T-cell lymphoma in bone marrow: a morphologic and immunophenotypic study.

Authors:  Faisal A Khokhar; William D Payne; Sameer S Talwalkar; Jeffrey L Jorgensen; Carlos E Bueso-Ramos; L Jeffrey Medeiros; Francisco Vega
Journal:  Hum Pathol       Date:  2009-09-08       Impact factor: 3.466

View more
  7 in total

1.  How useful is bone marrow study as an initial investigative tool without lymph node biopsy in malignant lymphoma?: Eleven years of experience at a single institution.

Authors:  Woo-Jae Kwoun; Jeong-Yeal Ahn; Pil-Whan Park; Yiel-Hea Seo; Kyung-Hee Kim; Ja Young Seo; Hwan Tae Lee; Kuai-Han Yoo
Journal:  J Clin Lab Anal       Date:  2019-02-06       Impact factor: 2.352

2.  Angioimmunoblastic T-cell lymphoma mimicking drug fever and infectious etiology after a thyroidectomy: A case report.

Authors:  Ping Han; Lan Yang; Wei Yan; Dean Tian
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

3.  Critical Role of Flow Cytometric Immunophenotyping in the Diagnosis, Subtyping, and Staging of T-Cell/NK-Cell Non-Hodgkin's Lymphoma in Real-World Practice: A Study of 232 Cases From a Tertiary Cancer Center in India.

Authors:  Prashant R Tembhare; Gaurav Chatterjee; Anumeha Chaturvedi; Niharika Dasgupta; Twinkle Khanka; Shefali Verma; Sitaram G Ghogale; Nilesh Deshpande; Karishma Girase; Manju Sengar; Bhausaheb Bagal; Hasmukh Jain; Dhanalaxmi Shetty; Sweta Rajpal; Nikhil Patkar; Tushar Agrawal; Sridhar Epari; Tanuja Shet; Papagudi G Subramanian; Sumeet Gujral
Journal:  Front Oncol       Date:  2022-03-01       Impact factor: 6.244

4.  Relapsed Angioimmunoblastic T Cell Lymphoma with Fulminant Leukemic Involvement.

Authors:  Rahaf Altahan; Areej AlMugairi; Muhamed Hitham Almahayni; Moussab Damlaj; Ahmad Al-Zghoul
Journal:  Am J Case Rep       Date:  2022-08-12

5.  PD-1 combined with TRBC1 and pan-T cell antibodies for robustly monitoring angioimmunoblastic T-cell lymphoma.

Authors:  Chunyan Wang; Li Zhu; Songya Liu; Shujuan Yi; Min Xiao; Yicheng Zhang; Xia Mao
Journal:  Front Med (Lausanne)       Date:  2022-09-08

6.  Assessment of T-cell receptor repertoire and clonal expansion in peripheral T-cell lymphoma using RNA-seq data.

Authors:  Qiang Gong; Chao Wang; Weiwei Zhang; Javeed Iqbal; Yang Hu; Timothy C Greiner; Adam Cornish; Jo-Heon Kim; Raul Rabadan; Francesco Abate; Xin Wang; Giorgio G Inghirami; Timothy W McKeithan; Wing C Chan
Journal:  Sci Rep       Date:  2017-09-12       Impact factor: 4.379

7.  The Early Diagnostic Dilemma in Angioimmunoblastic T Cell Lymphoma with Excessive Plasma Cells Proliferation.

Authors:  Chunyan Wang; Xia Mao; Songya Liu; Cheng He; Ying Wang; Li Zhu; Yangyang Wang; Yicheng Zhang
Journal:  Case Rep Med       Date:  2021-07-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.